Balance Sheet
Cash Flow Statement
AcquisitionsBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Capital Expenditures (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Capital Expenditures readings, the most recent being $797528.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 35.09% to $797528.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 45.37% decrease, with the full-year FY2025 number at $1.4 million, down 45.37% from a year prior.
  • Capital Expenditures hit $797528.0 in Q4 2025 for SBC Medical Group Holdings, up from $43053.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $6.2 million in Q4 2023 to a low of $43053.0 in Q3 2025.
  • Median Capital Expenditures over the past 3 years was $590358.0 (2024), compared with a mean of $1.1 million.
  • Biggest five-year swings in Capital Expenditures: plummeted 90.55% in 2024 and later skyrocketed 35.09% in 2025.
  • SBC Medical Group Holdings' Capital Expenditures stood at $6.2 million in 2023, then plummeted by 90.55% to $590358.0 in 2024, then skyrocketed by 35.09% to $797528.0 in 2025.
  • The last three reported values for Capital Expenditures were $797528.0 (Q4 2025), $43053.0 (Q3 2025), and $306706.0 (Q2 2025) per Business Quant data.